American Atomics Inc. (CSE:NUKE)

Blueprint Medicines Balance Sheet

Financials in millions CAD. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023
Cash & Equivalents	0.02	0.15	0.11
Cash & Short-Term Investments	0.02	0.15	0.11
Cash Growth	-53.46%	44.72%	-
Prepaid Expenses	0.04	0.03	0.08
Total Current Assets	0.07	0.18	0.19
Property, Plant & Equipment	0.7	0.26	0.06
Total Assets	0.76	0.45	0.24
Accounts Payable	0.07	0.1	0.03
Total Current Liabilities	0.11	0.1	0.03
Long-Term Debt	-	-	0.01
Other Long-Term Liabilities	-	0.04	-
Total Liabilities	0.11	0.14	0.05
Common Stock	1.08	0.49	0.23
Retained Earnings	-0.81	-0.2	-0.03
Comprehensive Income & Other	0.38	0.02	-
Shareholders' Equity	0.65	0.31	0.2
Total Liabilities & Equity	0.76	0.45	0.24
Total Debt	0.04	-	0.01
Net Cash (Debt)	-0.02	0.15	0.09
Net Cash Growth	-	65.69%	-
Net Cash Per Share	-0.00	0.01	0.02
Filing Date Shares Outstanding	46.2	20.83	16
Total Common Shares Outstanding	28.83	20.83	16
Working Capital	-0.05	0.09	0.16
Book Value Per Share	0.02	0.01	0.01
Tangible Book Value	0.65	0.31	0.2
Tangible Book Value Per Share	0.02	0.01	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.